Form 4: Kraig Biocraft Labs COO Exercises Stock Options in Recent Transaction
SEC Form 4
Chief Operating Officer of Kraig Biocraft Laboratories, Jonathan Richard Rice, recently exercised stock options, increasing his holdings in Class A Common Stock.
Summary
- On December 4, 2024, Jonathan Richard Rice, the Chief Operating Officer of Kraig Biocraft Laboratories, exercised stock options.
- These transactions involved the cashless exercise of stock options, resulting in the acquisition of Class A Common Stock.
- The exercises occurred with options priced at $0.0899 and $0.935.
- Following these transactions, Rice directly owns 4,320,121 shares of Class A Common Stock, 4,499,698 shares of Class A Common Stock, and 5,378,201 shares of Class A Common Stock.
- He also holds options for 181,518 shares and 888,000 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction. The exercise of options can be seen as a positive sign, but it also has the potential for dilution.
Positives
- The COO's exercise of stock options could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Risks
- The exercise of stock options could potentially dilute existing shareholders' equity.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. The exercise of options is a routine part of executive compensation.
Stakeholder Impact
- Existing shareholders may experience slight dilution due to the increase in the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 02/16/2016 | Date exercisable for some Class A Common Stock Options |
| 10/28/2016 | Date exercisable for some Class A Common Stock Options |
| 01/23/2025 | Expiration date for some Class A Common Stock Options |
| 01/15/2025 | Date exercisable for some Class A Common Stock Options |
| 05/28/2025 | Expiration date for some Class A Common Stock Options |
| 12/04/2024 | Date of transaction (exercise of stock options) |
| 03/24/2025 | Date of signature on the Form 4 |
Keywords
stock options, Kraig Biocraft Laboratories, KBLB, Form 4, insider trading, Jonathan Richard Rice, COO, Class A Common Stock, securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.